OUR RESOURCES
Video and slides 
CRSF Asco list of publications 
Ongoing studies 5th Master Class in Lung Cancer
Hall A Main Conference - MET - 23 July 2022
Interpretation Of MET Amplification On EXON 14 Skip Mutation In NSCLC
Selection Of 1st Line Therapy For MET Amplification And MET EXON 14 Mutation In NSLC
Mechanism Of Resistance To MET TKI And Therapy Post Resistance IN NSCLC
Interpretation Of MET Amplification On EXON 14 Skip Mutation In NSCLC
Selection Of 1st Line Therapy For MET Amplification And MET EXON 14 Mutation In NSLC
Mechanism Of Resistance To MET TKI And Therapy Post Resistance IN NSCLC